Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03370341 · ClinicalTrials.gov registry record · NA

Stimulating the Brain to Improve Self-Awareness

A NA study, sponsored by The University of Texas at Dallas.

Completed
Registry status
NA
Development phase
41
Enrollment target

NCT03370341: Completed NA study, sponsored by The University of Texas at Dallas.

NCT03370341 is a NA study that has completed, run by The University of Texas at Dallas. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03370341, a NA study, has completed, sponsored by The University of Texas at Dallas.

COMPLETED
Registry status
NA
Development phase
41 participants
Enrollment target

Study Summary

This study investigates whether Introspective Accuracy (IA) can be improved in individuals with schizophrenia by stimulating the brain via transcranial Direct Current Stimulation (tDCS).

Primary Outcome

Neurocognitive Introspective Accuracy (IA) was assessed with the Wisconsin Card Sorting Task after both Active and Sham stimulation. The area under a type 2 ROC (receiver operating characteristic) curve was used to index IA. Values range from .5-1, with higher values indicating better IA.

Interventions

  • DEVICE sham tDCS
  • DEVICE active anodal tDCS

Trial Details

FieldValue
Enrollment Target 41 participants
Start Date 2017-12-01
Est. Completion 2019-12-01
Phase NA
The University of Texas at Dallas

50 total trials

What the finished NCT03370341 record still lists

NCT03370341 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which sham tDCS is the first listed.

NCT03370341 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03370341 about?

NCT03370341 is a clinical study titled "Stimulating the Brain to Improve Self-Awareness". This study investigates whether Introspective Accuracy (IA) can be improved in individuals with schizophrenia by stimulating the brain via transcranial Direct Current Stimulation (tDCS).

What is the current status of trial NCT03370341?

This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2017-12-01. Estimated completion is 2019-12-01.

What interventions are being tested in trial NCT03370341?

The interventions under investigation include: sham tDCS (DEVICE), active anodal tDCS (DEVICE).

Who is sponsoring clinical trial NCT03370341?

This trial is sponsored by The University of Texas at Dallas, which has 50 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03370341's enrollment target sits among peer trials

41 1446th of 2000 higher than 554 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03449238 · 41 participants · Phase 1

    Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients

  • NCT03900793 · 41 participants · Phase 1

    Losartan + Sunitinib in Treatment of Osteosarcoma

  • NCT04082520 · 41 participants · Phase 2

    Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

  • NCT04220190 · 41 participants · Phase 2

    RAPA-501 Therapy for ALS

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03370341, the US trial registry maintained by the National Library of Medicine. NCT03370341 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.